Acquisition context Pulsar Vascular was acquired by Codman Neuro in December 2016, indicating integration into a larger neurovascular portfolio and potential for extended distribution channels and cross-sell opportunities with Codman’s customer base.

Neurovascular focus Specialization in minimally invasive devices for endovascular treatment of complex aneurysms positions the company to target Neurovascular surgeons and interventional radiologists seeking advanced solutions, aligning with centers of excellence and high-volume aneurysm programs.

Clinical stage assets As a clinical stage medical device manufacturer with a breakthrough platform for complex aneurysm therapy, there is potential to pursue partnerships or licensing with larger manufacturers, contract research organizations, or hospitals accelerating adoption through pivotal trials.

Financial signals Revenue range of 1–10 million suggests a small-to-mid-size footprint with room for growth through expanded adoption, enhanced reimbursement strategies, and scale through acquisition-driven integration within Codman’s ecosystem.

Strategic fit Location in San Jose and alignment with major players in medical devices imply opportunities to leverage regional life sciences networks, clinical centers, and procurement teams for pilots, case studies, and early-adopter programs within the neurovascular segment.